Welcome to our dedicated page for Aehr Test Sys SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aehr Test Systems (NASDAQ: AEHR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a California-based supplier of semiconductor test and burn-in systems, Aehr uses these filings to report on financial performance, corporate governance, equity compensation plans, and other material events.
Investors can review current reports on Form 8-K, where Aehr discloses items such as quarterly and annual financial results, amendments to equity incentive and employee stock purchase plans, and outcomes of shareholder votes at its annual meetings. For example, recent 8-K filings describe the approval of amendments to the 2023 Equity Incentive Plan and the Amended and Restated 2006 Employee Stock Purchase Plan, as well as the ratification of the company’s independent registered public accounting firm.
The company’s proxy statement on Schedule DEF 14A provides detail on director elections, executive compensation proposals, advisory votes on pay and pay frequency, and the matters submitted to shareholders at the annual meeting. These documents help investors understand Aehr’s board structure, compensation programs, and shareholder voting results.
On Stock Titan, Aehr’s filings are updated in near real time from EDGAR. Users can access 8-Ks for earnings announcements and other material events, proxy materials for governance and compensation information, and related exhibits referenced in those filings. AI-powered summaries highlight key points, allowing readers to quickly see how developments in Aehr’s semiconductor test and burn-in business—spanning FOX wafer-level systems and Sonoma, Echo, and Tahoe package-level platforms—are reflected in its official disclosures.
Aehr Test Systems (AEHR) filed a Form 4 disclosing that President & CEO Gayn Erickson had 2,489 common shares withheld on 07/11/2025 (transaction code F) at a price of $14.11 per share. The shares were automatically withheld by the issuer to cover statutory tax obligations triggered by the vesting of previously granted equity awards; no open-market sale occurred. After the withholding, Erickson retains 278,081 shares held directly and 291,088 shares held indirectly through a trust. The reported withholding represents less than 1 % of the executive’s aggregate beneficial ownership and does not signal a discretionary reduction in exposure to AEHR stock.
On July 11, 2025, Aehr Test Systems (ticker AEHR) Chief Operating Officer Adil Engineer filed a Form 4 reporting an administrative share disposition. The filing shows a Transaction Code "F," signifying that 580 common shares were automatically withheld at $14.11 each to cover tax obligations arising from the vesting of restricted stock units (RSUs). The aggregate value is roughly $8.2 thousand.
After the withholding, the executive continues to directly own 47,167 common shares, which includes unvested RSUs (as noted in footnote 2). No derivative securities were acquired or disposed of, and there were no open-market sales. Because the transaction is non-discretionary and involves a small share count relative to the officer’s total holdings, it is viewed as neutral in terms of market impact.
Aehr Test Systems (AEHR) Form 4 Filing Overview
Director Fariba Danesh reported the receipt of 9,253 shares of AEHR common stock on July 2, 2025 under a restricted stock unit (RSU) award, coded “A” for acquisition at a price of $0. After the grant, Danesh directly owns 25,643 shares, a total that includes unvested RSUs. The award vests in equal one-eighth installments every three months, contingent upon continued service on the board. No derivative securities were exercised or disposed of, and no open-market transactions occurred.
The filing appears to be part of routine director compensation rather than a discretionary purchase or sale. As such, it does not signal a material shift in ownership structure or insider sentiment, but it does modestly increase the director’s equity alignment with shareholders.
Form 4 filing – Aehr Test Systems (AEHR) submitted 07/03/2025 discloses insider transactions by Vernon Rogers, Executive Vice President of Sales & Marketing.
- 13,351 common shares (Transaction Code A) were acquired on 07/02/2025 through restricted stock unit (RSU) vesting at $0 cost. Footnote 1 states 1/16 of the award vests every three months.
- An additional 1,614 common shares (Code A) vested on the same date at $0 cost; 25% of this award vested immediately, with the remainder vesting quarterly over three years (Footnote 2).
- 218 shares (Code F) were withheld at $15.13 per share to satisfy tax-withholding obligations (Footnote 3); this is not an open-market sale.
- After all transactions, Mr. Rogers directly owns 70,390 AEHR shares, which include unvested RSUs (Footnote 4). The filing notes he previously received 6,486 shares upon termination of the company’s ESOP on 04/25/2025.
No derivative securities were reported. The filing reflects routine equity compensation vesting rather than discretionary market purchases or sales.
Form 4 overview: On 07/02/2025, Alistair N. Sporck, Vice-President of the Contractor Business Unit at Aehr Test Systems (AEHR), reported several equity transactions.
- Restricted Stock Units granted: 9,253 RSUs with quarterly vesting over four years (1/16 per quarter) and 2,276 RSUs with 25% immediate vesting and the balance vesting quarterly over three years. Both grants were recorded at a cost basis of $0.
- Tax-withholding transaction: 305 shares were automatically withheld at $15.13 to cover taxes on vested RSUs; this is classified as a disposition code “F” and does not represent an open-market sale.
- Post-transaction ownership: Sporck now directly owns 34,120 common shares and indirectly controls 3,993 shares through a trust.
- The filing notes an additional 936 shares received on 04/25/2025 from the termination of the company’s ESOP, included in the total.
No derivative securities were reported. The transactions reflect routine executive compensation and tax-withholding activity, with no cash proceeds to the insider and no change to the company’s share count.